Pharma stock gave 100% return

 

This pharma stock gave 100% return in 7 months

Gland Pharma's shares was listed on the stock exchange in November 2020. The company's stock has increased by more than 110 percent since its initial public offering (IPO) price of 1500 to now. During this time, the Nifty has only increased by 20%. Market analysts predict that the company's stock will grow 20% in the next 3 to 6 months. 

Gland Pharma's stocks have also surpassed their benchmark index this year by a large margin. While the Nifty 50 index has increased by 12% this year and the BSE 200 index has increased by 15%, Gland Pharma stocks have increased by 36%.

Gland Pharma's stock is expected to trade between Rs 3750 and Rs 3800 in the next 3 to 6 months, according to market analysts. Investors are also recommended to buy it on a slump in the Rs 3100 level. In other words, the company can pay investors up to 20% returns in the mid-term. On the NSE, the company's shares trading around Rs 3200.

Gland Pharma, which is owned by Shanghai Fosun Pharma, has a market capitalization of about Rs 52,000 crore, and its stocks hit an all-time high of Rs 3512 on May 19, 2021. Since then, the company's stock has been consolidating.

Gland Pharma has a unique business model, with B2B sales accounting for the majority of its revenue. In addition, the company's growth is mostly driven by its operations in the United States. Aside from that, the company has partnered with Russian Covid vaccine Sputnik-V to access the biosimilar market, which will benefit it.

The company's stocks have been in a steady ascent since February 2021, according to the technical chart. On the daily chart, it is making greater highs and lower lows. It has witnessed sideways and negative price corrections after hitting a new high last month.

The company's price correction period is completed, according to Ashish Chatuparmehta of Sanctum Wealth Management, and an uptick is forecast. He advised buyers to purchase it at the current price and set their stop loss at Rs 3000. The stock price of Kail Stocks is predicted to increase to Rs 3800.

Disclaimer

Source: moneycontrol